We are live on ! Find out more
PAS

Point72 Asia (Singapore) Portfolio holdings

AUM $646M
1-Year Est. Return 35.24%
This Fund
S&P 500
This Quarter Est. Return
-3.6%
1 Year Est. Return
+35.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$381M
AUM Growth
+$2.35M
Cap. Flow
+$31.8M
Cap. Flow %
8.34%
Top 10 Hldgs %
24.21%
Holding
1,276
New
435
Increased
204
Reduced
183
Closed
443

Top Buys

Rank Stock Value
1
CRDO icon
Credo Technology Group
CRDO
+$21.5M
2
K
Kellanova
K
+$13.2M
3
BLK icon
Blackrock
BLK
+$12.4M
4
TPR icon
Tapestry
TPR
+$7.66M
5
MSFT icon
Microsoft
MSFT
+$6.85M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$26.9M
2
CRM icon
Salesforce
CRM
+$14M
3
NFLX icon
Netflix
NFLX
+$11.7M
4
APH icon
Amphenol
APH
+$9.77M
5
AVGO icon
Broadcom
AVGO
+$7.54M

Sector Composition

Rank Sector Weight
1 Technology 21.26%
2 Financials 19.99%
3 Industrials 11.18%
4 Healthcare 10.51%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AX icon
876
Axos Financial
AX
$5.66B
-2,937
Closed -$205K
AXTI icon
877
AXT Inc
AXTI
$4.86B
-2
Closed -$4
BAH icon
878
Booz Allen Hamilton
BAH
$9.57B
-260
Closed -$33.4K
BANF icon
879
BancFirst
BANF
$3.8B
-1,793
Closed -$210K
BBCP icon
880
Concrete Pumping Holdings
BBCP
$472M
-3,070
Closed -$20.4K
BCAB icon
881
BioAtla
BCAB
$5.68M
-477
Closed -$14.1K
BDN
882
Brandywine Realty Trust
BDN
$539M
-5,912
Closed -$33.1K
BDSX icon
883
Biodesix
BDSX
$250M
-351
Closed -$10.7K
BEAM icon
884
Beam Therapeutics
BEAM
$2.77B
-7,708
Closed -$191K
BHC icon
885
Bausch Health
BHC
$2.32B
-1,074
Closed -$8.68K
CMRC
886
Commerce.com Inc Series 1
CMRC
$178M
-5,737
Closed -$35.1K
BIO icon
887
Bio-Rad Laboratories Class A
BIO
$9.42B
-1,909
Closed -$627K
BIRD icon
888
Smartbird Inc
BIRD
$22.5M
-3,429
Closed -$23.9K
BNY
889
Bank of New York Mellon
BNY
$109B
-22,238
Closed -$1.71M
BKNG icon
890
Booking.com
BKNG
$160B
-15,475
Closed -$3.08M
BKR icon
891
Baker Hughes
BKR
$64B
-30,913
Closed -$1.27M
BLFS icon
892
BioLife Solutions
BLFS
$1.7B
-1,194
Closed -$31K
BMY icon
893
Bristol-Myers Squibb
BMY
$130B
-81,262
Closed -$4.6M
BPMC
894
DELISTED
Blueprint Medicines
BPMC
-1,220
Closed -$106K
BRX icon
895
Brixmor Property Group
BRX
$9.13B
-202
Closed -$5.62K
BRY
896
DELISTED
Berry Corp
BRY
-1,313
Closed -$5.42K
BTAI icon
897
BioXcel Therapeutics
BTAI
$29.7M
-996
Closed -$5.96K
BSY icon
898
Bentley Systems
BSY
$10.6B
-5,649
Closed -$264K
BURL icon
899
Burlington
BURL
$23B
-469
Closed -$134K
BVN icon
900
Compañía de Minas Buenaventura
BVN
$8.82B
-61,645
Closed -$710K

Similar funds

Point72 Asia (Singapore)'s Q1 2025 Portfolio in Review

As of Q1 2025, Point72 Asia (Singapore) held 1,276 positions worth $381M, up 0.62% from $379M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Point72 Asia (Singapore) deployed $31.8M of net new capital in Q1 2025, opening 435 new positions and adding to 204 existing holdings. Its largest new stake was Credo Technology Group: 345,221 shares worth $13.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Broadcom, an estimated $7.54M trimmed.

  • Point72 Asia (Singapore)'s largest Q1 2025 buy was Credo Technology Group: 345,221 shares worth $13.9M.
  • Point72 Asia (Singapore) added most to Gilead Sciences in Q1 2025, an estimated $4.77M increase.
  • Point72 Asia (Singapore)'s biggest Q1 2025 reduction was Broadcom, cutting an estimated $7.54M.
  • Point72 Asia (Singapore) fully exited TSMC in Q1 2025, selling an estimated $26.9M.
  • Point72 Asia (Singapore)'s ten largest holdings make up 24% of its $381M portfolio in Q1 2025.
  • Point72 Asia (Singapore) opened 435 new positions and closed 443 in Q1 2025.
  • Point72 Asia (Singapore)'s portfolio value rose 0.62% quarter-over-quarter to $381M.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.